Elucidating mechanisms of rapid metastatic recurrence in pancreatic ductal adenocarcinoma

Ended Project Grant Awarded Last action

Award ID
W81XWH2210710
Recipient
Awarding agency
Obligated
$494,340

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Portland, OR 97239, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

Oregon Health & Science University was awarded a $494,340 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 2022 through July 2025 to elucidate mechanisms of rapid metastatic recurrence in pancreatic ductal adenocarcinoma. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care through innovative research and investigating medical solutions for battlefield wounds. This award will advance those goals by supporting Oregon Health & Science University's work to better understand pancreatic cancer recurrence, which could ultimately lead to improved treatment outcomes for Service Members and the general public.

Quick answers

Who received award W81XWH2210710?

W81XWH2210710 was awarded to Oregon Health & Science University by Medical Command (Department of the Army) on July 15, 2022.

How much is award W81XWH2210710 worth?

$494,340 has been obligated on W81XWH2210710.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login